A. Nikolaeva

Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia

G. Chkadua, B. Pinegin, M. Pashenkov, 2020, The Journal of Biological Chemistry.

Some pro- and anti-inflammatory cytokines, their genetic polymorphism and postinfarct cardiac remodeling

N. Babushkina, V. Ryabov, A. Nikolaeva, 2020 .

Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression

G. Chkadua, B. Pinegin, M. Pashenkov, 2021, The Journal of Immunology.

A comparative characterization of macrophages tolerant to NOD1 and TLR4 receptor agonists

M. Pashenkov, A. Nikolaeva, P. V. Maksimchik, 2021 .

[Studying the possibility of using immuno-enzy test system for evaluating anti-pertussis immunity.]

I. V. Feldblum, A. Nikolaeva, K. A. Subbotina, 2020, Klinicheskaia laboratornaia diagnostika.

The influence of glatiramer acetate on Th17-immune response in multiple sclerosis

A. Boyko, M. Pashenkov, V. Murugin, 2020, PloS one.

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS

O. V. Belyakova, V. Romanenko, A. Nikolaeva, 2018 .

Preclinical study of immunogenicity of adjuvanted quadrivalent subunit influenza vaccine

O. V. Belyakova, N. Mikhailova, I. Leneva, 2022, Journal of microbiology, epidemiology and immunobiology.

Phase I pharmacokinetics study of drug «COVID-globulin» (specific human immunoglobulin against COVID-19)

I. Shohin, A. Nikolaeva, N. Bagaeva, 2022, Drug development & registration.